z-logo
open-access-imgOpen Access
Osimertinib-Induced Cutaneous Vasculitis Responsive to Low-Dose Dapsone Without Interruption of Anticancer Therapy: A Case Report and Review of the Literature
Author(s) -
Christopher Iriarte,
Jonathan H. Young,
Michael S. Rabin,
Nicole R. LeBoeuf
Publication year - 2022
Publication title -
jto clinical and research reports
Language(s) - English
Resource type - Journals
ISSN - 2666-3643
DOI - 10.1016/j.jtocrr.2022.100415
Subject(s) - dapsone , medicine , osimertinib , dermatology , lung cancer , vasculitis , malignancy , systemic vasculitis , skin biopsy , discontinuation , cancer , biopsy , surgery , adenocarcinoma , pathology , disease , ros1

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom